DMVeille DM

Field safety notices: Mallinckrodt Pharmaceuticals Ireland Limited

Manufacturer registered in EUDAMED: SRN IE-MF-000000573 ; country: Ireland

3 authority publications by 3 authorities, from 12 Jun 2025 to 3 Jul 2026.

Latest notice: 3 Jul 2026, BfArM, CELLEX Photopheresis System Procedural Kit

Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Mallinckrodt Pharmaceuticals Ireland Limited or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.

2 distinct corrective actions.

  1. CELLEX Photopheresis System Procedural Kit

    Source: BfArM – Safety instructions in the field · collected 16 Nov 2026

Corrective action: 2 publications by AEMPS, ANSM, from 12 Jun 2025 to 12 Jun 2025

  1. Chimiothérapie extracorporelle – Therakos Cellex Photopheresis Procedural Kit

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

  2. Kit para procedimiento de fotoaféresis THERAKOS CELLEX, código de producto CLXECP

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

The authorities that published these notices